Novo Nordisk A/S
-
Business
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
[ad_1] A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made…
Read More » -
Health News
Here’s what Wall Street is saying about obesity drug Wegovy following Novo Nordisk’s key study
[ad_1] Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend.…
Read More » -
Pics News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
[ad_1] CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding…
Read More » -
Business
Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events
[ad_1] Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be…
Read More » -
Health News
Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom. Here’s why, analyst says
[ad_1] Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin,…
Read More » -
Business
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo…
Read More » -
Health News
The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick
[ad_1] Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they…
Read More » -
Pics News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli…
Read More » -
Business
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected adjusted loss for the…
Read More » -
Health News
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
[ad_1] Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don’t expect this duopoly to end soon,…
Read More »